IonQ (IONQ) entered the second half of the year with momentum after posting strong results in the second quarter. The quantum computing company lifted its sales outlook, secured a large capital raise, and advanced on major technology goals. However, IonQ’s earnings miss left analysts divided, with the market still split on how quickly its recent acquisitions and strategic partnerships will translate into profits.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Growing Revenue, Acquisitions, Partnerships
IonQ reported revenue of $20.7 million for the second quarter, which was 15% above the high end of its guidance. The increase reflected stronger demand for its systems and services. The company also announced a one billion dollar investment from an affiliate of Susquehanna, completed at a 25% premium to its prior market price. Management raised its full year revenue forecast to between $82 million and $100 million, up from the earlier midpoint of $85 million.
The company is expanding through acquisitions aimed at boosting its technical capabilities. It has closed the purchase of Capella and is awaiting regulatory approval in the United Kingdom to finalize its acquisition of Oxford Ionics. These deals are tied to IonQ’s plan to reach 800 logical qubits by 2027 and 80,000 by 2030. The company also signed agreements with Japan’s AIST and South Korea’s KISTI, and committed $22 million to build the first commercial quantum computing hub in the United States. In addition, IonQ is working with AstraZeneca (AZN), AWS (AMZN), and NVIDIA (NVDA), achieving a 20 times improvement in certain drug development processes.
Bulls vs. Bears
As stated in the opening, the Street is still split on IonQ. The bulls point to the revenue beat as a sign of traction in a fast-emerging market. The one-billion-dollar cash boost is seen as a vote of confidence from a major investor and a resource to fund research without immediate pressure to raise more capital. They also note the global partnerships and new hires, including prominent scientists Dr. Chris Monroe and Dr. Marco Pistoia, as positive signals.
For instance, five-star analyst Quinn Bolton kept his Buy rating on IonQ with a $60 price target, suggesting over 40% upside. He did so after the company beat Q2 2025 revenue estimates, raised its full-year forecast, made early progress on key projects, added talent through hiring and an acquisition, and strengthened its position in quantum computing with a new Oxford Ionics partnership and leadership changes.
The bears, on the other hand, see risks in the rising cost base. Operating expenses rose 201% year-over-year to $181.3 million, while stock-based compensation climbed to $99.2 million. The company widened its loss outlook, and its acquisition pace could add integration challenges. Questions remain about the timeline to reach technical goals and achieve profitability. On this side of the fence, we have D.A. Davidson’s five-star analyst, Alex Platt, who downgraded IONQ to a Hold from a Buy and a $35 price target, suggesting a 16% downside from the current price.
Is IonQ Stock a Buy, Sell, or Hold?
The overall sentiment on IonQ among the Street’s analysts is still positive, with a Moderate Buy consensus rating. The average price target of IonQ stock is $49.57, suggesting an 18.45% upside from the current price.
